- The 30 most traded Non-STI stocks in the YTD span 10 Sectors, with just over half of the 30 stocks outpacing the STI total returns and 18 of the 30 stocks booking net institutional inflows over the past 15 weeks. The market value of the 30 stocks varies from above S$16 billion to near S$250 million.
- Among the 30 stocks, the 10 stocks that booked the highest YTD net institutional inflows proportionate to market cap included Best World, YZJ Fin Hldg, CapLand China Trust, Frencken, Golden Agri-Res, Nanofilm, Raffles Medical, Sheng Siong, Samudera Shipping and Top Glove with returns varying from 65% for Samudera Shipping to 4% for YZJ Fin Hldg.
- In 2022, Samudera Shipping achieved record earnings, ventured into warehousing and distribution centre in Indonesia and took delivery of two units of 20,000 DWT chemical tankers for the international market. The stock has also posted the strongest 5 year total return of the 30 most traded Non-STI stocks.
As detailed here, the STI generated a 2.4% total return over the first 15 weeks of 2023 amid a global macro background of persistent inflation and decelerating growth. Ongoing geopolitical tensions also saw manufacturing and wholesale trade weigh 1Q23 Adv GDP growth to +0.1% YoY. With a combined market capitalisation of S$509 billion, together the 30 STI stocks averaged daily trading turnover of S$855 million over the first 15 weeks of 2023, while booking S$2.0 billion of net institutional outflow.
By comparison, the next 30 most traded stocks in the year through to 17 April, maintain a combined market capitalisation of S$84 billion, while averaging daily trading turnover of S$167 million and booking S$37 million of net institutional outflow. These 30 most traded Non-STI stocks in the 2023 year to 17 April span as many as 10 Sectors, with just over half of the 30 stocks outpacing the STI total returns over the period.
The strongest performer of the 30 stocks in both the 2023 year to 17 April and past five years was Samudera Shipping Line. For its FY22, Samudera Shipping Line delivered a record performance with revenue growing 88.0% to US$990.6 million, from US$527.0 million recorded in FY21. The Group noted that the delivery of two of the six container newbuilds last year that it had secured on long-term operating leases also afforded Samudera Shipping Line greater flexibility to support its customers. The six newbuilds form part of its strategy to rejuvenate the fleet with younger, larger and more fuel-efficient vessels. To better serve its customers amid rising demand, the Group also expanded our tanker fleet during the year, and effectively doubled the fleet of chemical tankers from two to four.
In addition, 18 of the 30 most traded non-STI stocks booked net institutional inflows over the past 15 weeks. The market value of the 30 stocks varies from above S$16 billion for NIO Inc to near S$250 million for Rex International. While NIO Inc, is the largest of the 30 stocks by market capitalisation, the past five sessions saw the stock maintain the third narrowest bid/ask spread of the group, in terms of basis points after Haw Par Corporation and AEM Holdings. NIO Inc shares traded in Singapore and NYSE traded ADS are fully fungible, thus holders and shareholders can convert shares trading on SGX to ADS trading on NYSE, and vice-versa. NIO Inc has declined 4.4% in the 2023 year to 17 April in USD terms, while Contemporary Amperex Technology which makes up 6.4% of the FTSE China A50 Index has gained 4.0% in USD terms.
Among the 30 stocks, the 10 stocks that booked the highest YTD net institutional inflows proportionate to market capitalisation generated positive returns for the period. These included Best World International, Yangzijiang Financial Holding, CapitaLand China Trust, Frencken Group, Golden Agri-Resources, Nanofilm Technologies International, Raffles Medical Group, Sheng Siong Group, Samudera Shipping Line and Top Glove Corporation Bhd.
The 30 most traded non-STI stocks sort by average daily trading turnover in the 2023 year to 17 April are tabled below.
| 30 Most Traded Non-STI stocks in YTD | Code | YTD Avg Daily T/O (S$M) | Mkt Cap $M | YTD Net Insti Flow S$M | YTD Total Return % | 5 Year Total Return % | Beta | P/B (x) | 5yr P/B (x) | Sector | Past 5 sessions Avg Bid/Ask Spread (bps) |
| Sembcorp Marine | S51 | 42 | 8,078 | 25.4 | -14.5 | -90.4 | 1.8 | 1.0 | 0.9 | Industrials | 84 |
| Suntec REIT | T82U | 12 | 4,170 | -102.4 | 5.8 | -0.5 | 0.9 | 0.6 | 0.8 | REITs | 69 |
| ComfortDelGro | C52 | 8 | 2,653 | -47.7 | -0.8 | -32.4 | 1.0 | 1.0 | 1.5 | Industrials | 83 |
| UMS | 558 | 8 | 706 | 0.2 | -11.0 | 44.1 | 1.5 | 2.1 | 2.3 | Technology | 92 |
| CapLand Ascott T | HMN | 6 | 3,710 | 5.5 | 4.0 | 13.3 | 1.2 | 0.8 | 0.8 | REITs | 95 |
| Golden Agri-Res | E5H | 6 | 3,466 | 31.8 | 8.0 | -8.1 | 1.0 | 0.5 | 0.5 | Consumer Non-Cyclicals | 181 |
| Lendlease REIT | JYEU | 6 | 1,643 | -23.5 | 3.5 | -5.2 | 1.1 | 0.7 | 0.8 | REITs | 71 |
| Samudera Shipping | S56 | 6 | 749 | 4.1 | 65.5 | 717.2 | 1.5 | 1.0 | 0.5 | Industrials | 76 |
| AEM SGD | AWX | 5 | 1,029 | 3.6 | -3.8 | 114.9 | 1.3 | 2.1 | 4.2 | Technology | 33 |
| Frasers Cpt Tr | J69U | 5 | 3,974 | 12.6 | 10.5 | 32.7 | 0.5 | 1.0 | 1.1 | REITs | 45 |
| Nanofilm | MZH | 5 | 1,118 | 9.6 | 20.9 | -41.6 | 0.7 | 2.6 | 7.3 | Technology | 60 |
| Frencken | E28 | 5 | 467 | 6.3 | 15.3 | 110.9 | 1.4 | 1.2 | 1.4 | Technology | 91 |
| YZJ Fin Hldg | YF8 | 4 | 1,466 | 21.8 | 4.2 | -40.3 | 0.9 | 0.4 | 0.4 | Financial Services | 133 |
| Olam Group | VC2 | 4 | 6,322 | 0.1 | 12.3 | -3.8 | 0.9 | 0.8 | 0.8 | Consumer Non-Cyclicals | 62 |
| CapLand China T | AU8U | 4 | 1,916 | 26.0 | 4.7 | 1.8 | 0.7 | 0.8 | 0.8 | REITs | 89 |
| ESR-LOGOS REIT | J91U | 4 | 2,536 | -3.2 | -5.8 | -10.5 | 1.0 | 0.8 | 0.9 | REITs | 153 |
| First Resources | EB5 | 4 | 2,408 | -7.9 | 2.7 | 5.8 | 1.1 | 1.4 | 1.8 | Consumer Non-Cyclicals | 65 |
| Sheng Siong | OV8 | 3 | 2,655 | 17.3 | 6.7 | 103.3 | 0.1 | 5.9 | 6.0 | Consumer Non-Cyclicals | 58 |
| Haw Par | H02 | 3 | 2,170 | -18.0 | 2.0 | -12.9 | 0.6 | 0.6 | 0.8 | Healthcare | 24 |
| Raffles Medical | BSL | 3 | 2,795 | 19.7 | 5.7 | 43.3 | 0.8 | 2.7 | 2.4 | Healthcare | 68 |
| Keppel Infra Tr | A7RU | 3 | 2,579 | -9.4 | -1.3 | 35.6 | 0.5 | 1.6 | 1.7 | Utilities | 97 |
| Best World | CGN | 3 | 1,059 | 25.4 | 31.5 | 8.1 | 1.3 | 2.2 | 5.3 | Consumer Cyclicals | 48 |
| NetLink NBN Tr | CJLU | 3 | 3,421 | -7.8 | 5.4 | 43.6 | 0.3 | 1.3 | 1.2 | Telecommunications | 58 |
| NIO Inc. USD OV* | NIO | 3 | 16,421 | 1.5 | -4.4 | -44.1 | 1.9 | 4.7 | 5.7 | Consumer Cyclicals | 34 |
| CapLand India T | CY6U | 2 | 1,274 | -14.8 | -0.2 | 45.6 | 0.5 | 1.0 | 1.2 | REITs | 93 |
| Rex Intl | 5WH | 2 | 245 | -7.5 | -13.5 | 272.8 | 2.0 | 1.0 | 1.1 | Energy/ Oil & Gas | 55 |
| CDL H Trust | J85 | 2 | 1,516 | 0.6 | 0.3 | -11.9 | 1.5 | 0.8 | 0.9 | REITs | 83 |
| DigiCore REIT USD* | DCRU | 2 | 500 | -9.1 | -16.6 | -53.3 | 1.3 | 0.5 | 1.0 | REITs | 115 |
| Geo Energy Res | RE4 | 2 | 469 | -7.5 | 1.5 | 117.7 | 1.2 | 0.9 | 1.0 | Energy/ Oil & Gas | 149 |
| Top Glove | BVA | 2 | 2,613 | 10.5 | 18.5 | -33.3 | 1.2 | 1.3 | 4.9 | Healthcare | 150 |
| Total/Average | 167 | 84,128 | -37 | 5 | 44 |
*Note Mkt Cap and returns in USD. Note 5 year total returns are dated from debut, if counter listed over past 5 years.
Source: SGX, Refinitiv (Data as of 17 April 2023)
—
Originally Posted April 18, 2023 – Recent Highlights of a Tier of 30 Stocks Beyond the STI Benchmark
Disclosure: Interactive Brokers
Information posted on IBKR Campus that is provided by third-parties does NOT constitute a recommendation that you should contract for the services of that third party. Third-party participants who contribute to IBKR Campus are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.
This material is from Singapore Exchange and is being posted with its permission. The views expressed in this material are solely those of the author and/or Singapore Exchange and Interactive Brokers is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to buy or sell any security. It should not be construed as research or investment advice or a recommendation to buy, sell or hold any security or commodity. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.
Disclosure: Alternative Investments
Alternative investments can be highly illiquid, are speculative and may not be suitable for all investors. Investing in Alternative investments is only intended for experienced and sophisticated investors who have a high risk tolerance. Investors should carefully review and consider potential risks before investing. Significant risks may include but are not limited to the loss of all or a portion of an investment due to leverage; lack of liquidity; volatility of returns; restrictions on transferring of interests in a fund; lower diversification; complex tax structures; reduced regulation and higher fees.
Join The Conversation
If you have a general question, it may already be covered in our FAQs. If you have an account-specific question or concern, please reach out to Client Services.